Deciphering the Genetic Architecture of Autoimmune Diseases | MicrobiomeTrials← Back to trialsNCT06948110
Deciphering the Genetic Architecture of Autoimmune Diseases
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-09-16Est. Completion: 2030-04-22
Enrollment target: 300 participants Locations- National Human Genome Research Institute (NHGRI), Bethesda, Maryland, United States
- Amazon Rainforest, Lima, Peru
Other microbiome trials you might be interested in
DermatomyositisPolymyositisInclusion Body Myositis
This study will evaluate subjects with adult- and childhood-onset myositis to learn more about their cause and the immun…
Atlanta, United States
NMOSDNeuromyelitis Optica Spectrum Disorder
The primary objective of this study is to confirm the efficacy, safety, pharmacokinetics (PK), pharmacodynamics (PD), an…
Beijing, ChinaEst. completion Sep 19, 2028
Phase 2
Recruiting
Primary Immune Thrombocytopenia (ITP)
The purpose of this study is to evaluate the therapeutic efficacy, safety and tolerability of ianalumab in adult patient…
Boston, United StatesEst. completion Feb 5, 2025